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Venous thromboembolism prophylaxis - beware
of potential risks
Van Zyl et al’s study1 highlights the importance of increased
awareness of venous thromboembolism (VTE) in mental
health services for older people. However, it is also important
to be aware of the risks of thromboprophylaxis within this
setting. The authors claim that the incidence rates of VTE in
old age mental health services were comparable with those in
general hospitals. However, it does not follow from this that the
same approaches for VTE screening and thromboprophylaxis
used in general hospitals should be applied, particularly with
respect to the risks of thrombocytopenia and bleeding from
prophylactic low molecular weight heparin,2 which may be
exacerbated in mental health in-patient settings, where the
average length of stay is likely to be longer than in an acute
medical unit. In fact, recent meta-analyses have questioned
whether such risks outweigh the potential beneﬁts even within
the general hospital setting.3 Further evidence should be
sought before such VTE prevention strategies are widely
implemented in mental healthcare settings, lest they lead to
patient harm.
1 van Zyl M,Wieczorek G, Reilly J. Venous thromboembolism incidence in
mental health services for older people: survey of in-patient units.
Psychiatrist 2013; 37: 283-5.
2 Wang TY, Honeycutt EF, Tapson VF, Moll S, Granger CB, Ohman EM.
Incidence of thrombocytopenia among patients receiving heparin
venous thromboembolism prophylaxis. Am J Med 2012; 125: 1214-21.
3 Lederle FA, Zylla D, Macdonald R, Wilt TJ. Venous thromboembolism
prophylaxis in hospitalized medical patients and those with stroke: a
background review for an American College of Physicians Clinical
Practice Guideline. Ann Intern Med 2011; 155: 602-15.
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Venous thromboembolism risk assessment
in old age psychiatry
Venous thromboembolism (VTE) risk assessment for patients
admitted to old age psychiatric units has been a neglected
area.1 Both the National Institute for Health and Care
Excellence’s and the Department of Health’s guidelines2,3
recommend that every patient admitted to hospital be
assessed for VTE and managed appropriately. The failure to
adequately screen and prevent VTE is believed to cause
annually between 25000 and 32000 potentially avoidable
deaths in the UK.4
During my 6-month rotation in old age psychiatry, we
completed an audit looking into VTE risk assessment for
elderly patients. The results were quite alarming: 13% of
patients developed deep vein thrombosis (DVT). We then
looked at DVT risk factors retrospectively and this revealed a
mean of 3.4 risk factors for patients admitted to our unit. Not
one patient had been assessed for VTE or treated on admission
with pharmacological prophylaxis or graded compression
stockings. Old age psychiatric units do not seem to have
policies in place to recognise and manage patients accordingly,
in contrast to general hospitals, where every patient undergoes
a VTE assessment on admission and is commenced on
appropriate prophylaxis immediately.
Unfortunately, both the risks of thrombosis and those
associated with prophylactic treatment are increased in frail
older people, and this means that careful risk assessment to
weigh up the risks and beneﬁts in each patient is essential.
A more standardised national approach and greater awareness
of the Department of Health’s risk assessment tool for VTE3
may be needed.
1 van Zyl M, Wieczorek G, Reilly J. Venous thromboembolism incidence
in mental health services for older people: survey of in-patient units.
Psychiatrist 2013; 37: 283-5.
2 National Collaborating Centre for Acute and Chronic Conditions.Venous
Thromboembolism - Reducing the Risk. Reducing the Risk of Venous
Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in
Patients Admitted to Hospital (NICE Clinical Guideline 92). NICE, 2010.
3 Department of Health. Venous Thromboembolism (VTE) Risk Assessment
(Gateway reference 10278). Department of Health, 2010.
4 Roopen A (ed.) Venous Thromboembolism Prevention: A Patient Safety
Priority. King’s Thrombosis Centre, 2009.
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Diverse response from psychiatrists to CTOs
I thank Dr Lawton-Smith for his comments on our paper on
community treatment orders (CTOs).1,2 I ﬁnd it necessary,
however, to emphasise that we never implied that all
psychiatrists like the new CTOs. In fact, we merely pointed out
that they have been used much more than the Department of
Health anticipated. In that sense they have been popular with
practising psychiatrists.
We are fully aware that many psychiatrists in England and
Wales are uneasy with the legislation. I also agree that the
recent Burns et al paper3 may well cause a reduction in CTOs
used.
1 Lawton-Smith SH. CTOs - use with caution (letter). Psychiatrist 2013;
37: 308.
2 Lepping P, Malik M. Community treatment orders: current practice and
a framework to aid clinicians. Psychiatrist 2013; 37: 54-7.
3 Burns T, Rugka˚sa J, Molodynski A, Dawson J, Yeeles K, Vazquez-Montes
M, et al. Community treatment orders for patients with psychosis
(OCTET): a randomised controlled trial. Lancet 2013; 381: 1627-33.
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The risk in risk assessment
Szmukler et al1 should be warmly congratulated on their clear,
authoritative critique of the recent developments in the law of
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